Barriers to adherence and their solutions

Sep 1, 2019 by in ENDOCRINOLOGY Comments Off on Barriers to adherence and their solutions

3 Barriers to adherence and their solutions Management plans in type 2 diabetes may have many components, which may be extremely challenging. These include dietary and physical activity recommendations, administration…

read more

Personalised management

Sep 1, 2019 by in ENDOCRINOLOGY Comments Off on Personalised management

6 Personalised management Optimal management of individuals with type 2 diabetes involves complex decision-making to achieve and maintain control of blood glucose as well as other risk factors. The blueprint…

read more

Challenges to glycaemic control

Sep 1, 2019 by in ENDOCRINOLOGY Comments Off on Challenges to glycaemic control

2 Challenges to glycaemic control Achieving and maintaining adequate glycaemic control remains a challenge in many people with type 2 diabetes. The most recent National Institute for Health and Care…

read more

New insulin developments

Sep 1, 2019 by in ENDOCRINOLOGY Comments Off on New insulin developments

Related posts: Challenges to glycaemic control Personalised management Type 2 diabetes: epidemiology, complications and costs Type 2 diabetes: epidemiology, complications and costs Organisation of diabetes care Barriers to adherence and…

read more

Organisation of diabetes care

Sep 1, 2019 by in ENDOCRINOLOGY Comments Off on Organisation of diabetes care

7 Organisation of diabetes care ROLE OF THE PRIMARY CARE TEAM IN MULTI-PROFESSIONAL CARE An important consequence of a chronic condition such as type 2 diabetes is that it is…

read more

Regulation of Adrenal Steroidogenesis

Sep 1, 2019 by in ENDOCRINOLOGY Comments Off on Regulation of Adrenal Steroidogenesis

Fig. 2.1 Steroid biosynthetic pathways in the human adrenal cortex. Shown are enzymes (underlined) and intermediates in the biosynthesis of adrenal steroid hormones. 17α-Hydroxypregnenolone is the preferred substrate for the…

read more

Diagnosis and Management of Primary Aldosteronism

Sep 1, 2019 by in ENDOCRINOLOGY Comments Off on Diagnosis and Management of Primary Aldosteronism

Aldosterone-producing adenoma (APA)—30% of cases Bilateral idiopathic hyperplasia (IHA)—60% of cases Primary (unilateral) adrenal hyperplasia—2% of cases Aldosterone-producing adrenocortical carcinoma—<1% of cases Familial hyperaldosteronism (FH)  Glucocorticoid-remediable aldosteronism (FH type 1)—<1%…

read more
Get Clinical Tree app for offline access